ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 87 filers reported holding ALX ONCOLOGY HLDGS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,000 | -43.3% | 3,680 | -8.0% | 0.00% | – |
| Q2 2023 | $30,000 | +500.0% | 4,001 | +226.6% | 0.00% | – |
| Q1 2023 | $5,000 | -83.9% | 1,225 | -55.6% | 0.00% | – |
| Q4 2022 | $31,000 | +1450.0% | 2,762 | +958.2% | 0.00% | – |
| Q3 2022 | $2,000 | +100.0% | 261 | +117.5% | 0.00% | – |
| Q2 2022 | $1,000 | -94.4% | 120 | -89.0% | 0.00% | – |
| Q1 2022 | $18,000 | -73.1% | 1,089 | -65.2% | 0.00% | – |
| Q4 2021 | $67,000 | +737.5% | 3,133 | +2800.9% | 0.00% | – |
| Q3 2021 | $8,000 | +700.0% | 108 | +369.6% | 0.00% | – |
| Q2 2021 | $1,000 | -99.0% | 23 | -98.3% | 0.00% | – |
| Q1 2021 | $99,000 | +4850.0% | 1,347 | +5080.8% | 0.00% | – |
| Q4 2020 | $2,000 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 9,699,925 | $163,929,000 | 36.34% |
| Logos Global Management LP | 3,011,352 | $50,892,000 | 6.60% |
| Vivo Capital, LLC | 4,220,048 | $71,319,000 | 4.91% |
| Samsara BioCapital, LLC | 262,786 | $4,441,000 | 1.12% |
| Cormorant Asset Management, LP | 712,079 | $12,034,000 | 0.92% |
| Pier Capital, LLC | 394,443 | $6,666,000 | 0.85% |
| Redmile Group, LLC | 772,397 | $13,054,000 | 0.41% |
| Artal Group S.A. | 500,000 | $8,450,000 | 0.35% |
| Nan Fung Group Holdings Ltd | 41,950 | $709,000 | 0.34% |
| Orbimed Advisors | 621,700 | $10,507,000 | 0.17% |